How Admission to a Vascular Surgery Department Improves Medical Treatment in Patients with Lower Extremity Peripheral Arterial Disease

Annals of Vascular Surgery

Volumn 40, Issue , 2017, Pages 85-93

  Thiney, Martina ^a   Della Schiava, Nellie ^a   Feugier, Patrick ^a,b   Lermusiaux, Patrick ^a,b   Ninet, Jacques ^a,b   Millon, Antoine ^a,b   Long, Anne ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CARDIOVASCULAR AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; DISEASE SEVERITY; ENDOVASCULAR SURGERY; FEMALE; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LEG DISEASE; LEG REVASCULARIZATION; LOWER EXTREMITY PERIPHERAL ARTERIAL DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; UNIVERSITY HOSPITAL; VENOUS THROMBOEMBOLISM; CLINICAL PRACTICE; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; DRUG UTILIZATION REVIEW; HEALTH CARE DELIVERY; HOSPITAL DEPARTMENT; LOWER LIMB; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SPECIALIZATION; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR AGENTS; DELIVERY OF HEALTH CARE; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION REVIEW; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOWER EXTREMITY; MALE; MIDDLE AGED; PATIENT ADMISSION; PATIENT DISCHARGE; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; PRACTICE PATTERNS, PHYSICIANS'; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPECIALIZATION; SURGERY DEPARTMENT, HOSPITAL; TREATMENT OUTCOME;

EID: 85009355145     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2016.08.030     Document Type: Article

References (18)

1. 1 Hooi, J., Kester, A., Stoffers, H., et al. Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study. J Clin Epidemiol 57 (2004), 294–300.
2. 2 Hirsch, A., Haskal, Z., Hertzer, N., et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease. Circulation 113S (2006), e463–e654.
3. 3 HAS. Prise en charge de l'artériopathie chronique oblitérante athéroscléreuse des membres inférieurs (indications médicamenteuses, de revascularisation et de rééducation). Argumentaire 2006.
4. 4 Tendera, M., Aboyans, V., Bartelink, M., et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32 (2011), 2851–2906.
5. 5 Rooke, T., Hirsch, A., Misra, S., et al. ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 58 (2011), 2020–2045.
6. 6 HAS. Recommandations de bonne pratique. Bon usage des agents antiplaquettaires. Recommandations. 2012.
7. 7 Alonso-Coello, P., Bellmunt, S., McGorrian, C., et al. Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141 (2012), e669S–e690S.
8. 8 Bhatt, D., Steg, P., Ohman, E., et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295 (2006), 180–189.
9. 9 Khan, S., Flather, M., Mister, R., et al. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry. Eur J Vasc Endovasc Surg 33 (2007), 442–450.
10. 10 Flu, H., Tamsma, J., Lindeman, J., et al. A systematic review of implementation of established recommended secondary prevention measures in patients with PAOD. Eur J Vasc Endovasc Surg 39 (2010), 70–86.
11. 11 Steenhof, N., Le Piane, F., Leblanc, K., et al. Vascular quality of care pilot study: how admission to a vascular surgery service affects evidence-based pharmacologic risk factor modification in patients with lower extremity peripheral arterial disease. Vasc Health Risk Manag 10 (2014), 333–340.
12. 12 De Martino, R.R., Eldrup-Jorgensen, J., Nolan, B.W., et al. Vascular Study Group of New England. Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery. J Vasc Surg 59 (2014), 1615–1621 1621.e1.
13. 13 De Martino, R.R., Hoel, A.W., Beck, A.W., et al. Vascular Quality Initiative. Participation in the Vascular Quality Initiative is associated with improved perioperative medication use, which is associated with longer patient survival. J Vasc Surg 61 (2015), 1010–1019.
14. 14 Sigvant, B., Kragsterman, B., Falkenberg, M., et al. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization. J Vasc Surg 64 (2016), 1009–1017.e3.
15. 15 Stroes, E.S., Thompson, P.D., Corsini, A., et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J 36 (2015), 1012–1022.
16. 16 Jackevicius, C.A., Mamdani, M., Tu, J.V., Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288 (2002), 462–467.
17. 17 Dicpinigaitis, P.V., Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest 129 (2006), 169S–173S.
18. 18 Annual report SWEDEHEART 2012. Scand Cardiovasc J 48 (2014), 2–133.